Kalvista Cash And Short Term Investments vs Total Current Liabilities Analysis
KALV Stock | USD 11.86 0.25 2.06% |
Kalvista Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating Kalvista Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Kalvista Pharmaceuticals is a good investment. Please check the relationship between Kalvista Pharmaceuticals Cash And Short Term Investments and its Total Current Liabilities accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kalvista Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Kalvista Stock please use our How to Invest in Kalvista Pharmaceuticals guide.
Cash And Short Term Investments vs Total Current Liabilities
Cash And Short Term Investments vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Kalvista Pharmaceuticals Cash And Short Term Investments account and Total Current Liabilities. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Kalvista Pharmaceuticals' Cash And Short Term Investments and Total Current Liabilities is 0.44. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Kalvista Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Kalvista Pharmaceuticals' Cash And Short Term Investments and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of Kalvista Pharmaceuticals are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Cash And Short Term Investments i.e., Kalvista Pharmaceuticals' Cash And Short Term Investments and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | 0.44 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Cash And Short Term Investments
Short Term Investments is an account in the current assets section of Kalvista Pharmaceuticals balance sheet. This account contains Kalvista Pharmaceuticals investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Kalvista Pharmaceuticals fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Total Current Liabilities
Total Current Liabilities is an item on Kalvista Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Kalvista Pharmaceuticals are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from Kalvista Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Kalvista Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kalvista Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Kalvista Stock please use our How to Invest in Kalvista Pharmaceuticals guide.Issuance Of Capital Stock is likely to climb to about 58.6 M in 2024, whereas Selling General Administrative is likely to drop slightly above 4.6 M in 2024.
2023 | 2024 (projected) | Net Interest Income | 2.6M | 2.7M | Non Recurring | 1.3M | 1.2M |
Kalvista Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Kalvista Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Kalvista Pharmaceuticals fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 118.1M | 92.5M | 272.0M | 203.9M | 183.2M | 88.7M | |
Short Long Term Debt Total | 54K | 1.6M | 5.9M | 8.2M | 8.2M | 4.6M | |
Other Current Liab | 5.5M | 6.9M | 7.0M | 9.1M | 29K | 27.6K | |
Total Current Liabilities | 18.1M | 7.7M | 9.8M | 11.6M | 15.0M | 4.1M | |
Total Stockholder Equity | 96.7M | 83.8M | 257.2M | 185.1M | 161.0M | 66.4M | |
Property Plant And Equipment Net | 3.7M | 7.5M | 10.0M | 10.8M | 12.4M | 13.0M | |
Net Debt | (14.1M) | (44.7M) | (22.5M) | (48.0M) | (43.2M) | (41.0M) | |
Retained Earnings | (92.5M) | (121.6M) | (167.8M) | (250.2M) | (343.1M) | (76.3M) | |
Accounts Payable | 2.9M | 1.7M | 2.0M | 3.6M | 4.8M | 2.0M | |
Cash | 32.0M | 15.8M | 50.6M | 30.7M | 56.2M | 32.8M | |
Non Current Assets Total | 3.8M | 7.7M | 10.2M | 10.9M | 12.5M | 13.1M | |
Cash And Short Term Investments | 100.8M | 67.7M | 248.9M | 166.2M | 149.4M | 77.5M | |
Common Stock Total Equity | 17K | 18K | 24K | 25K | 34K | 18.2K | |
Common Stock Shares Outstanding | 17.7M | 19.1M | 24.5M | 27.9M | 32.1M | 33.7M | |
Liabilities And Stockholders Equity | 92.5M | 272.0M | 203.9M | 183.2M | 210.7M | 221.2M | |
Non Current Liabilities Total | 1.1M | 5.0M | 7.2M | 7.1M | 6.4M | 11.2M | |
Other Current Assets | 4.5M | 4.9M | 10.6M | 6.4M | 1.0M | 959.5K | |
Other Stockholder Equity | 207.2M | 426.4M | 439.1M | 507.1M | (75K) | (71.3K) | |
Total Liab | 21.4M | 8.8M | 14.8M | 18.8M | 22.2M | 7.1M | |
Property Plant And Equipment Gross | 2.4M | 3.7M | 7.5M | 10.0M | 10.8M | 764.8K | |
Total Current Assets | 115.5M | 88.7M | 264.3M | 193.6M | 172.3M | 85.2M | |
Accumulated Other Comprehensive Income | (1.9M) | (1.9M) | (1.4M) | (3.9M) | (3.1M) | (659.4K) | |
Short Term Debt | 54K | 588K | 863K | 977K | 1.1M | 1.2M | |
Common Stock | 17K | 18K | 24K | 25K | 34K | 15.9K | |
Capital Surpluse | 191.1M | 207.2M | 426.4M | 439.1M | 507.1M | 115.8M | |
Property Plant Equipment | 2.4M | 2.0M | 1.8M | 2.2M | 2.9M | 1.3M | |
Net Tangible Assets | 83.8M | 257.2M | 185.1M | 161.0M | 43.1M | 40.9M | |
Net Receivables | 11.3M | 16.5M | 10.4M | 14.1M | 16.6M | 2.1M | |
Retained Earnings Total Equity | (71.7M) | (92.5M) | (121.6M) | (167.8M) | (250.2M) | (343.1M) | |
Net Invested Capital | 83.8M | 257.2M | 185.1M | 161.0M | 185.2M | 132.4M | |
Net Working Capital | 81.0M | 254.5M | 182.1M | 157.3M | 180.9M | 132.0M | |
Capital Lease Obligations | 1.6M | 5.9M | 8.2M | 8.2M | 9.5M | 9.9M | |
Capital Stock | 18K | 24K | 25K | 34K | 39.1K | 26.0K |
Pair Trading with Kalvista Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kalvista Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kalvista Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Kalvista Stock
Moving against Kalvista Stock
The ability to find closely correlated positions to Kalvista Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kalvista Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kalvista Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kalvista Pharmaceuticals to buy it.
The correlation of Kalvista Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kalvista Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kalvista Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kalvista Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Kalvista Stock Analysis
When running Kalvista Pharmaceuticals' price analysis, check to measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.